Wegovy Savings Card in 2026

If you have commercial (employer or marketplace) insurance that covers Wegovy on its formulary, the Wegovy Savings Card can bring your copay to as little as $0 for a 28-day supply, up to a maximum monthly and annual savings set by Novo Nordisk. If your plan does NOT cover Wegovy, the card does not lower the price — the realistic route is NovoCare cash-pay at about $349/month maintenance ($199/month introductory), not the ~$1,349 list price.

You need a valid US prescription and commercial insurance. The largest savings ($0-copay tier) requires that your commercial plan actually covers Wegovy. Patients whose plan excludes Wegovy get a smaller benefit off the cash price. By federal law, anyone with Medicare, Medicaid, TRICARE, VA, or any government plan cannot use the card at all.

Federal anti-kickback law bars drug manufacturers from offering copay cards to patients enrolled in any government health program. This is not a Wegovy-specific rule — it applies to every brand-drug copay card. If you have Medicare or Medicaid, your options are a formulary appeal (if your plan might cover it), or the NovoCare cash-pay program.

Yes. The card caps both the per-fill savings and a total annual savings amount, and both change year to year — that is why we date this page and link Novo Nordisk's official terms rather than printing a fixed number that goes stale. Always confirm the current monthly and annual maximum on NovoCare before you rely on it for budgeting.

The Savings Card lowers a copay for commercially-insured patients whose plan covers Wegovy. NovoCare cash-pay (also from Novo Nordisk) is a flat self-pay price — about $349/month maintenance, $199/month introductory — for people who are uninsured or whose plan does not cover Wegovy. You use one or the other, not both.